FDA Authorizes Booster COVID-19 Shots for Vulnerable, Immunocompromised People

A man receiving a COVID-19 vaccine in a file photo on July 10, 2021. Ben Birchall/PA

The Food and Drug Administration (FDA) on Thursday authorized a booster shot of Pfizer-BioNTech’s and Moderna’s COVID-19 vaccines for certain vulnerable and immunocompromised people.

Those who will be able to access the third dose of the vaccines include “specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise,” the FDA said in a statement.